Katherine A. Brakora

Inhibition of <i>ABCB1</i> (<i>MDR1</i>) and <i>ABCB4</i> (<i>MDR3</i>) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells

Zhenfeng Duan, Katherine A. Brakora, Michael V. Seiden · Molecular Cancer Therapeutics · 2004 · 171 citations · Full text

Medicine, Oncology, Pharmacology +16

GBP1 overexpression is associated with a paclitaxel resistance phenotype

Zhenfeng Duan, Rosemary Foster, Katherine A. Brakora et al. · Cancer Chemotherapy and Pharmacology · 2005 · 62 citations

Medicine, Cancer Biology, Oncology +11

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer

Katherine A. Brakora, H Lee, Rukh Yusuf et al. · Gynecologic Oncology · 2004 · 51 citations

Medicine, Gynecology, Oncology +9

BMS-247550 Bristol-Myers Squibb/GBF.

Katherine A. Brakora, Michael V. Seiden · PubMed · 2003 · 23 citations

Medicine, Oncology, Pharmacology +15

<i>FGFR‐</i>associated craniosynostosis syndromes and gastrointestinal defects

Christine Elizabeth Hibberd, Sarah Bowdin, Yamini Arudchelvan et al. · American Journal of Medical Genetics Part A · 2016 · 19 citations · Full text

Medicine, Genetics, Molecular Genetics +15